Nerai Bio raises €4.0M Seed round

2 June 2025· Zurich, Switzerland· health, drug_discovery, ai, robotics, genome_editing, b2b, software_hardware

Nerai Bioscience's mission is to overcome limitations in gene editing and develop curative genetic medicines accessible to everyone. The company is actively fundraising and seeking strategic partnerships to build its network, gain exposure, and explore collaborations, implying the funds will support product development and scaling.